National Oxygen Ltd
Incorporated in 1974, National Oxygen Ltd is a manufacturer and supplier of Industrial
Gases both in Liquid and Gaseous form[1]
- Market Cap ₹ 61.3 Cr.
- Current Price ₹ 122
- High / Low ₹ 165 / 95.0
- Stock P/E
- Book Value ₹ -15.9
- Dividend Yield 0.00 %
- ROCE -21.5 %
- ROE %
- Face Value ₹ 10.0
Pros
- Debtor days have improved from 37.8 to 29.3 days.
- Company's working capital requirements have reduced from 25.2 days to 14.8 days
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -1.57% over past five years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Industrial Gases
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
25.80 | 28.13 | 33.17 | 36.09 | 41.36 | 46.21 | 43.93 | 39.76 | 50.61 | 47.11 | 45.26 | 40.58 | |
26.08 | 29.58 | 30.36 | 31.49 | 35.74 | 37.63 | 37.54 | 33.49 | 39.18 | 43.43 | 44.02 | 43.05 | |
Operating Profit | -0.28 | -1.45 | 2.81 | 4.60 | 5.62 | 8.58 | 6.39 | 6.27 | 11.43 | 3.68 | 1.24 | -2.47 |
OPM % | -1.09% | -5.15% | 8.47% | 12.75% | 13.59% | 18.57% | 14.55% | 15.77% | 22.58% | 7.81% | 2.74% | -6.09% |
0.10 | 0.11 | 0.35 | 0.33 | 2.19 | 3.42 | 0.27 | 0.40 | 1.44 | 0.59 | 0.50 | 0.28 | |
Interest | 3.57 | 5.43 | 6.10 | 6.46 | 5.90 | 4.90 | 4.80 | 4.48 | 2.15 | 1.79 | 1.64 | 1.59 |
Depreciation | 3.86 | 4.17 | 3.94 | 3.91 | 3.79 | 3.53 | 3.41 | 3.28 | 3.09 | 3.27 | 3.33 | 3.22 |
Profit before tax | -7.61 | -10.94 | -6.88 | -5.44 | -1.88 | 3.57 | -1.55 | -1.09 | 7.63 | -0.79 | -3.23 | -7.00 |
Tax % | -30.88% | -1.01% | -17.30% | -0.55% | -0.53% | 0.00% | 0.65% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
-5.26 | -10.83 | -5.68 | -5.41 | -1.87 | 3.56 | -1.57 | -1.10 | 7.63 | -0.79 | -3.23 | -7.00 | |
EPS in Rs | -10.95 | -22.55 | -11.83 | -11.27 | -3.89 | 7.41 | -3.27 | -2.29 | 15.89 | -1.65 | -6.41 | -13.88 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | 4% |
5 Years: | -2% |
3 Years: | -7% |
TTM: | -10% |
Compounded Profit Growth | |
---|---|
10 Years: | 3% |
5 Years: | % |
3 Years: | % |
TTM: | -113% |
Stock Price CAGR | |
---|---|
10 Years: | 11% |
5 Years: | 28% |
3 Years: | 7% |
1 Year: | -16% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | % |
Balance Sheet
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 | 4.80 | 5.04 | 5.04 |
Reserves | 12.75 | 1.34 | -4.35 | -11.45 | -13.31 | -9.74 | -11.34 | -12.41 | -4.79 | -5.73 | -6.04 | -13.05 |
37.52 | 43.33 | 48.40 | 49.01 | 44.06 | 38.09 | 38.60 | 37.21 | 32.82 | 29.06 | 28.65 | 30.70 | |
7.47 | 7.88 | 7.00 | 6.74 | 6.37 | 6.04 | 6.16 | 6.39 | 6.97 | 6.78 | 6.45 | 8.41 | |
Total Liabilities | 62.54 | 57.35 | 55.85 | 49.10 | 41.92 | 39.19 | 38.22 | 35.99 | 39.80 | 34.91 | 34.10 | 31.10 |
52.61 | 48.77 | 44.88 | 39.81 | 35.24 | 31.91 | 29.01 | 26.48 | 24.27 | 22.07 | 21.98 | 19.58 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.03 | 0.03 | 0.03 | 0.03 | 0.06 | 0.00 | 0.14 | 0.81 | 0.18 |
Investments | 0.77 | 0.56 | 0.16 | 0.01 | 0.11 | 0.17 | 0.19 | 0.21 | 0.10 | 0.05 | 0.08 | 0.33 |
9.16 | 8.02 | 10.81 | 9.25 | 6.54 | 7.08 | 8.99 | 9.24 | 15.43 | 12.65 | 11.23 | 11.01 | |
Total Assets | 62.54 | 57.35 | 55.85 | 49.10 | 41.92 | 39.19 | 38.22 | 35.99 | 39.80 | 34.91 | 34.10 | 31.10 |
Cash Flows
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-2.37 | 1.30 | 1.49 | 4.87 | 8.45 | 7.85 | 4.83 | 6.53 | 11.59 | 2.23 | 0.97 | -0.18 | |
-4.36 | -1.67 | -0.45 | 0.71 | 2.68 | 3.12 | -0.39 | -0.70 | 0.40 | -0.62 | -3.69 | -0.21 | |
6.77 | 0.39 | -1.03 | -5.85 | -10.86 | -10.86 | -4.30 | -5.87 | -6.54 | -5.93 | 1.07 | 0.45 | |
Net Cash Flow | 0.04 | 0.02 | 0.01 | -0.27 | 0.28 | 0.11 | 0.14 | -0.04 | 5.46 | -4.32 | -1.66 | 0.07 |
Ratios
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 62.53 | 46.71 | 66.46 | 45.41 | 32.92 | 33.33 | 40.71 | 45.90 | 36.35 | 41.37 | 42.74 | 29.32 |
Inventory Days | ||||||||||||
Days Payable | ||||||||||||
Cash Conversion Cycle | 62.53 | 46.71 | 66.46 | 45.41 | 32.92 | 33.33 | 40.71 | 45.90 | 36.35 | 41.37 | 42.74 | 29.32 |
Working Capital Days | -24.05 | -64.36 | -33.23 | -42.78 | -34.86 | -6.79 | 20.85 | 26.07 | 20.12 | 29.52 | 31.29 | 14.75 |
ROCE % | -7.83% | -10.43% | -1.67% | 2.15% | 5.44% | 15.05% | 9.85% | 10.90% | 27.81% | 3.28% | -5.88% | -21.49% |
Documents
Announcements
-
Regulation 23(9) - Non Applicability Certificate
30 May - Company exempt from related party transaction disclosure under SEBI LODR for H1 FY25.
- Financial Results For The Year Ended 31St March 2025 29 May
-
Board Meeting Outcome for Held On 29Th May 2025
29 May - Approved FY25 audited results with net loss; appointed internal and secretarial auditors; sold land reducing liabilities.
-
Board Meeting Intimation for Meeting To Be Held On 29Th May 2025
26 May - Board meeting on 29 May 2025 to approve audited financial results for FY ended 31 March 2025.
-
Disclosure Of Non- Identification As Large Corporate With Reference To SEBI Circular Sebl/HO/DDHS/CIR/P/2021/613 DATED 10 AUGUST, 2021(UPDATED AS ON 19Th October 2023)
9 Apr - Company not classified as Large Corporate per SEBI guidelines.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Product Profile:[1]
a) High Pure Liquid Oxygen
b) High Pure Gaseous Oxygen
c) High Pure Liquid Nitrogen
d) Medical Grade Oxygen Liquid
e) Medical Grade Oxygen Gas
f) High Purity Nitrogen Gas
g) Dissolved Acetylene Gas